These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2671522)

  • 1. Role of the clinical laboratory in the diagnosis and management of malignant melanoma.
    Scott RE; Wilson DM
    Mayo Clin Proc; 1989 Jul; 64(7):837-45. PubMed ID: 2671522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry of malignant melanoma.
    Schwartz MK
    Ann Clin Lab Sci; 1976; 6(1):56-64. PubMed ID: 813557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
    Beyer C; Fiedler H; Wohlrab W; Wozniak KD
    Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
    [No Abstract]   [Full Text] [Related]  

  • 4. Production, circulation, and excretion of melanin-related metabolites in B16 melanoma-bearing mice.
    Wakamatsu K; Ito S; Fujita K
    Acta Derm Venereol; 1990; 70(5):367-72. PubMed ID: 1980967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiences of the demonstration of indole melanogens in urine in malignant melanomas].
    Lahmer H; Jung HD
    Z Arztl Fortbild (Jena); 1971 Mar; 65(6):316-7. PubMed ID: 4997800
    [No Abstract]   [Full Text] [Related]  

  • 6. Melanin-related metabolites as markers of melanoma: a review.
    Ito S
    J Dermatol; 1992 Nov; 19(11):802-5. PubMed ID: 1293166
    [No Abstract]   [Full Text] [Related]  

  • 7. Markers of melanogenesis in malignant melanoma.
    Matous B; Bubnova E; Budesinska A; Kostirova M
    Sb Lek; 1994; 95(4):333-38. PubMed ID: 8867704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of urinary melanogens in patients with melanosarcoma].
    Humbel R
    Pharm Acta Helv; 1972 Jan; 47(1):29-40. PubMed ID: 5013185
    [No Abstract]   [Full Text] [Related]  

  • 9. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
    Paul E; Graef V; Ruppel R
    Z Hautkr; 1980 Dec; 55(23):1543-60. PubMed ID: 6782780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in children.
    Meyerhöffer S; Lindberg Z; Häger A; Kågedal B; Rosdahl I
    Acta Derm Venereol; 1998 Jan; 78(1):31-5. PubMed ID: 9498023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-S-cysteinyldopa in urine and tumors.
    Hara H; Chino K; Kawanami T; Sameshima T; Morishima T
    J Dermatol; 1992 Nov; 19(11):806-8. PubMed ID: 1293167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data processing of urine chromatograms for the clinical management of melanoma.
    Banda PW; Tuttle MS; Selmer LE; Thatachari YT; Sherry AE; Blois MS
    Comput Biomed Res; 1980 Dec; 13(6):549-66. PubMed ID: 6780261
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
    Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
    Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indole melanogens--useful tumor markers in malignant melanoma?].
    Ghussen F; Nagel K; Groth W; Horbach G
    Z Hautkr; 1985 Oct; 60(20):1613-9. PubMed ID: 4060826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the excretion of different types of melanogens in the melanoma patients.
    Matous B; Pavel S; Budĕsínská A; Duchon J; Mechl Z; Sopková B
    Neoplasma; 1979; 26(5):597-602. PubMed ID: 118388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
    Wakamatsu K; Ito S; Fujita K
    Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic melanoma and melanogenuria.
    Aivaz O; Gaertner EM; Norton SA
    Cutis; 2012 Mar; 89(3):125-8. PubMed ID: 22530329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
    Ito S; Wakamatsu K; Inoue S; Fujita K
    Acta Derm Venereol; 1989; 69(5):380-4. PubMed ID: 2572100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Melanogens in the diagnosis of melanoma].
    Kubiński Z
    Nowotwory; 1987; 37(1):10-5. PubMed ID: 3628026
    [No Abstract]   [Full Text] [Related]  

  • 20. Trichochromes in the urine of melanoma patients.
    Agrup G; Lindbladh C; Prota G; Rorsman H; Rosengren AM; Rosengren E
    J Invest Dermatol; 1978 Feb; 70(2):90-1. PubMed ID: 621413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.